← Back to patent-cliff list
CMS-D002
Tier C — Watch / tradeCMS-D002
-
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：GnRH
Indications (approved)：子宫肌瘤, 子宫肿瘤, Endometriosis, Pain, Gynaecological disorder
Regional status
US
-
EU
-
China
Phase II
2026-02-19
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of CMS-D002?
Approved indications include: 子宫肌瘤, 子宫肿瘤, Endometriosis, Pain, Gynaecological disorder.
When does the CMS-D002 patent expire?
No public expiry year is available for CMS-D002 yet; this page updates once verified.
How do I get a quote for CMS-D002 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-29